{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:14:11Z","timestamp":1789010051945,"version":"build-2803163510"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,12,8]]},"DOI":"10.18632\/oncotarget.5705","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T08:52:05Z","timestamp":1446022325000},"page":"42362-42371","source":"Crossref","is-referenced-by-count":25,"title":["High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival"],"prefix":"10.18632","volume":"6","author":[{"given":"Shuhua","family":"Yi","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Zhong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengjun","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Xiong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enbin","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"},{"name":"Department of Hematology, Tianjin First Center Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ru","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihong","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"An","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Lv","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Qi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Kluin","year":"2011","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/asheducation-2014.1.90","article-title":"Diagnosis of \u2018double hit\u2019 diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC","volume":"2014","author":"Swerdlow","year":"2014","journal-title":"Hematology"},{"key":"3","first-page":"155","article-title":"Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature","volume":"6","author":"Shao","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/10428194.2012.710329","article-title":"An aggressive B-cell lymphoma with rearrangements of MYC and CCND1 genes: a rare subtype of double-hit lymphoma","volume":"54","author":"Delmer","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3343\/alm.2012.32.1.95","article-title":"CD5-negative blastoid variant mantle cell lymphoma with complex CCND1\/IGH and MYC aberrations","volume":"32","author":"Lee","year":"2012","journal-title":"Ann Lab Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2004-10-3907","article-title":"Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome","volume":"105","author":"Martinez-Climent","year":"2005","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Medeiros","year":"2002","journal-title":"Mod Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.prp.2012.12.001","article-title":"Unusual concomitant rearrangements of Cyclin D1 and MYC genes in blastoid variant of mantle cell lymphoma: Case report and review of literature","volume":"209","author":"Laurent","year":"2013","journal-title":"Pathol Res Pract"},{"key":"9","doi-asserted-by":"crossref","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","article-title":"c-MYC-induced genomic instability","volume":"4","author":"Mai","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","article-title":"Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management","volume":"90","author":"Vose","year":"2015","journal-title":"Am J Hematol"},{"key":"11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","article-title":"Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur","volume":"158","author":"Ehinger","year":"2012","journal-title":"Br J Haematol"},{"key":"12","doi-asserted-by":"crossref","first-page":"iii83","DOI":"10.1093\/annonc\/mdu264","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Ladetto","year":"2014","journal-title":"Ann Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1182\/blood-2012-12-473090","article-title":"The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop","volume":"122","author":"Thomas-Tikhonenko","year":"2013","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Jedrzejczak","year":"2013","journal-title":"N Engl J Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.18632\/oncotarget.426","article-title":"Novel targeted therapies for mantle cell lymphoma","volume":"3","author":"Baiocchi","year":"2012","journal-title":"Oncotarget"},{"key":"16","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.18632\/oncotarget.2255","article-title":"Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed\/refractory aggressive B-cell non-hodgkin lymphoma","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"17","first-page":"457","article-title":"MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications","volume":"1846","author":"Juszczynski","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Campo","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/bies.1135","article-title":"Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?","volume":"23","author":"Blagosklonny","year":"2001","journal-title":"Bioessays"},{"key":"20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Catovsky","year":"2007","journal-title":"Br J Haematol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature","volume":"25","author":"Montserrat","year":"2007","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3324\/haematol.12330","article-title":"Genomic aberrations in mantle cell lymphoma detected by interphase fluorescencehybridization. Incidence and clinicopathological correlations","volume":"93","author":"Stilgenbauer","year":"2008","journal-title":"Haematologica"},{"key":"23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Carrio","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"24","article-title":"CDKN2A and TP53 deletions predict adverse outcome in younger mantle cell lymphoma patients, independent of treatment and MIPI","author":"Hermine","year":"2015","journal-title":"Blood"},{"key":"25","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Moroy","year":"1994","journal-title":"EMBO J"},{"key":"26","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Adams","year":"1994","journal-title":"EMBO J"},{"key":"27","first-page":"p194","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"V","year":"2008","edition":"4"},{"key":"28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/10428194.2010.531411","article-title":"TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia","volume":"52","author":"Qiu","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1080\/10428190600687547","article-title":"Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis","volume":"47","author":"Troussard","year":"2006","journal-title":"Leuk Lymphoma"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T02:23:04Z","timestamp":1718158984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,23]]},"references-count":29,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2015,12,8]]}},"alternative-id":["5705","26517511"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5705","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,23]]}}}